Steven Cohen’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-55,619
Closed -$318K – 4391
2026
Q2
$318K Buy
+55,619
New +$320K ﹤0.01% 3361
2026
Q1
– Sell
-11,965
Closed -$147K – 4286
2025
Q4
$147K Buy
+11,965
New +$196K ﹤0.01% 3693
2024
Q1
– Sell
-77,520
Closed -$1.11M – 2502
2023
Q4
$1.11M Buy
+77,520
New +$744K ﹤0.01% 1375
2023
Q3
– Sell
-461,716
Closed -$6.6M – 2766
2023
Q2
$6.6M Sell
461,716
-14,476
-3% -$206K 0.02% 726
2023
Q1
$6.97M Buy
+476,192
New +$7.97M 0.02% 661
2022
Q1
– Sell
-145,100
Closed -$9.01M – 1330
2021
Q4
$9.01M Buy
+145,100
New +$11M 0.04% 538

Other funds holding OPRX

Steven Cohen's OPRX Position: Q3 2026 in Review

Steven Cohen sold out of OptimizeRx (OPRX) in Q3 2026, closing a stake of 55,619 shares — an estimated $318K sold.

Steven Cohen first reported a position in OPRX in Q4 2021 and held it in 6 quarters. The position peaked at $9.01M in Q4 2021. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

  • Steven Cohen reported no remaining OptimizeRx position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 55,619 OptimizeRx shares in Q3 2026, an estimated $318K.
  • Steven Cohen first reported a position in OptimizeRx in Q4 2021 and held it in 6 quarters.
  • Steven Cohen's OptimizeRx position peaked at $9.01M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.